Invicta Diagnostic share news, announcements and annual reports
NSE: INVICTAHealthcare Services
Share price at the NSE close on 29 Oct 2026. Previous close ₹65.00.
29 Oct: open ₹64.50, high ₹64.50, low ₹64.50
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹81 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 16.53
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.62
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Dec 2025
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 9.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.07
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,200100.0% delivered
Invicta Diagnostic has 44 announcements on record, routine notices left out; none in the 30 days to 30 Oct 2026, the latest on 19 Sep 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Invicta Diagnostic half-yearly results
The board met on 18 May 2026 to consider financial results
Notice filed 13 May 2026
To consider and approve the financial results for the period ended March 31, 2026
Invicta Diagnostic annual reports, presentations and earnings calls
The company's own documents, latest first.Invicta Diagnostic financials, year by year
Annual reports1
- Annual report, year to Mar 202625 Aug 2026
Investor presentations1
- Presentation22 May 2026
Earnings calls2
- Transcript of Earnings Conference Call with Investor and Analyst held on Saturday, 23rd May 2026.25 May 2026
- Link of audio recording of the Investor and Analyst Earnings Conference Call held on Saturday, 23rd May, 2026 at 12:00 P.M. (IST) to discuss the operational and financial in relation to the financial results of the Company for the half year ended 31st March, 2026.23 May 2026
Invicta Diagnostic share news and announcements
Newest first.
Sep 2026
19 Sep · Meeting
17 Sep · Commencement of commercial production/operations
Aug 2026
25 Aug · Board meeting
Jul 2026
29 Jul · Management
23 Jul · Management
Jun 2026
30 Jun · Commencement of commercial production/operations
1 Jun · Business
May 2026
29 May · Business
22 May · Business
19 May · Analysts
16 May · Sale or disposal
13 May · Board meeting
Apr 2026
11 Apr · Business
Mar 2026
25 Mar · Board meeting
Feb 2026
Jan 2026
30 Jan · Commencement of commercial production/operations
Dec 2025
17 Dec · Updates
17 Dec · Updates
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 31 Jul 2026Board or managers changedup 2.10%+1.6 pts vs Nifty 500market median 0.0% · five sessions +18.4% (+16.7 pts vs Nifty 500) · volume 1.8× usual · The announcement
- 21 Jul 2026Board or managers changedup 4.92%+4.9 pts vs Nifty 500market median 0.0% · five sessions +1.1% (+1.9 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 18 May 2026Resultsdown 4.97%−4.7 pts vs Nifty 500market median −0.7% · five sessions −21.4% (−21.9 pts vs Nifty 500) · volume 1.0× usual · The announcement
Invicta Diagnostic results filing dates and deadlines
Listed companies must file half-yearly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.